Back
Inozyme Pharma Vs. Builders FirstSource Industry Stock Comparison
Buy
73
INZY
Inozyme Pharma
Last Price:
4.61
Seasonality Move:
-12.13%
Sell
49
BLDR
Builders FirstSource
Last Price:
167.00
Seasonality Move:
6.7%
Buy
73
Inozyme Pharma (INZY)
is a Buy
Is Inozyme Pharma a Buy, Sell or Hold?
- The current Inozyme Pharma [INZY] share price is $4.60. The Score for INZY is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- INZY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Builders FirstSource (BLDR)
is a Sell
Is Builders FirstSource a Buy, Sell or Hold?
- The current Builders FirstSource [BLDR] share price is $167.05. The Score for BLDR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- BLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INZY Stock Price Chart
What is Inozyme Pharma's stock price today?
-
The Inozyme Pharma share price today is $4.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INZY is experiencing selling pressure, which indicates risk of future bearish movement.
BLDR Stock Price Chart
What is Builders FirstSource's stock price today?
-
The Builders FirstSource share price today is $167.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLDR is experiencing slight selling pressure.
INZY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 42.67 | Sell |
| Chaikin Money Flow: | -160122 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.44 - 4.72) | Buy |
| Bollinger Bands (100): | (4.42 - 6.14) | Sell |
BLDR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.4 | Sell |
| Relative Strength Index (14 RSI): | 39.78 | Sell |
| Chaikin Money Flow: | -337678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (168.74 - 189.2) | Sell |
| Bollinger Bands (100): | (169.66 - 198.36) | Sell |
INZY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.62 | Sell |
| 20-day SMA: | 4.56 | Buy |
| 50-day SMA: | 5.37 | Sell |
| 200-day SMA: | 4.64 | Sell |
| 8-day EMA: | 4.63 | Sell |
| 20-day EMA: | 4.73 | Sell |
| 50-day EMA: | 5.05 | Sell |
| 200-day EMA: | 4.88 | Sell |
BLDR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 167.64 | Sell |
| 20-day SMA: | 178.45 | Sell |
| 50-day SMA: | 189.88 | Sell |
| 200-day SMA: | 158.52 | Buy |
| 8-day EMA: | 170.04 | Sell |
| 20-day EMA: | 176.53 | Sell |
| 50-day EMA: | 182.8 | Sell |
| 200-day EMA: | 161.7 | Buy |
Inozyme Pharma Earnings Growth & INZY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.04 per share.
Builders FirstSource Earnings Growth & BLDR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.49 per share, a decrease this year of $0.87 per share, and an increase next year of $1.33 per share.
Inozyme Pharma Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Builders FirstSource Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||